SCHEMBL27009705

SCHEMBL27009705

Cc1cc(C(C)N)c2oc(-c3ccccc3)cc(=O)c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.60
▸ PIK3CA P42336 1/20 0.60
▸ PIK3CB P42338 1/20 0.60
▸ PIK3CG P48736 1/20 0.60
▸ CYP3A4 P08684 7/20 0.53
▸ TP53 P04637 6/20 0.53
▸ HPGD P15428 6/20 0.53
▸ MAPT P10636 6/20 0.53
▸ ALDH1A1 P00352 5/20 0.53
▸ CSNK2A2 P19784 4/20 0.53
▸ CSNK2B P67870 4/20 0.53
▸ CSNK2A1 P68400 4/20 0.53
▸ KDM4E B2RXH2 4/20 0.53
▸ HSD17B10 Q99714 4/20 0.53
▸ CYP1B1 Q16678 5/20 0.49
▸ CYP1A1 P04798 4/20 0.49
▸ CYP1A2 P05177 4/20 0.49
▸ CYP19A1 P11511 4/20 0.47
▸ MAPK1 P28482 3/20 0.47
▸ ABCB1 P08183 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30742078 1.00 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL26884886 1.00 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL24912684 0.87 PIK3CD (0.60) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL26884771 0.86 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL27129922 0.86 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL27008503 0.83 PIK3CA (0.65) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL27132077 0.83 PIK3CA (0.65) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL26884767 0.82 CYP1A1 (0.52) PIK3CDPIK3CAPIK3CBPIK3CGMAPT
SCHEMBL27130132 0.82 CYP1A1 (0.52) PIK3CDPIK3CAPIK3CBPIK3CGMAPT
SCHEMBL24912995 0.81 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PIK3CA, PIK3R4, PIK3R5 PIK3CD 6/4885PIK3CA 1/4885PIK3CB 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback